New Digital Tracking Initiative Aims to Improve Patient Safety
The government has approved the implementation of a barcode system for medicines as part of efforts to combat counterfeit and substandard drugs in the market. The move is expected to strengthen the monitoring of pharmaceutical products and enhance patient safety across the country.
Under the new system, medicine manufacturers will be required to place unique barcodes on drug packaging. The barcodes will allow regulators, pharmacies, healthcare providers, and consumers to verify the authenticity of medicines through digital scanning technology.
Health officials say the initiative will improve transparency throughout the pharmaceutical supply chain by enabling authorities to track medicines from production facilities to retail outlets. The system is also expected to help identify counterfeit products more quickly and prevent their distribution.
Experts have welcomed the decision, noting that fake medicines pose serious risks to public health and can undermine confidence in healthcare systems. They believe the barcode system will make it easier to monitor drug quality and ensure that patients receive genuine and approved medicines.
Authorities are expected to work closely with pharmaceutical companies and healthcare stakeholders to ensure the smooth implementation of the new requirements. Awareness campaigns may also be launched to educate consumers on how to verify medicines using barcode technology.
Officials expressed confidence that the initiative will strengthen regulatory oversight, improve public trust in pharmaceutical products, and contribute to safer healthcare outcomes nationwide.
